ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced that it intends to offer, subject to market and other conditions, 5,000,000 shares of its common stock in an underwritten public offering. ImmunoGen expects to grant the underwriters a thirty (30) day option to purchase up to 750,000 additional shares to cover over-allotments, if any.
Tags: ImmunoGen, SharesCurrently viewing and reading
Related Post
- PPG Anticipates Strong Second Quarter Results (June 18th, 2010)
- Oriental Financial Group Reports First Quarter 2010 Income Available to Common Shareholders of $10.7 Million (April 21st, 2010)
- Mentor Capital, Inc. Completes 2nd Year Audit for OTCBB Move; Reporting $0.16 Per Share in Basic Earnings (September 22nd, 2009)
- Walter Energy Announces Second Quarter 2009 Earnings of $0.21 Per Diluted Share (July 24th, 2009)
- Discover Financial Services Announces Pricing of Public Offering of Common Stock (July 8th, 2009)
Business News
- Pragmatic Software Partners With Aculis
- Trigent Named to Software Magazine’s 26th Annual Software 500
- Women’s Health, Fitness and Wellness Online Store for ‘Women Over 40′ Opens Today
- Custom Health Plans Revamps Web site and Launches Blog to Help Consumers Find the Best Options for Affordable Health Insurance
- Untitled
- FirstAgain’s ‘Back to Basics’ Underwriting Bolsters Recession-Resistant Business Model for Online Consumer Lender Focusing on ‘Superprime’ Borrowers
- Klatu Adds Integrated Product Licensing and Export and Import Documentation Functionality
- Womens-Health.com Supports National Women’s Health Week With Fitness Challenge
- Jeffrey Rhodes Joins CSG Government Solutions’ Unemployment Insurance Practice
- Get More Work Done Faster With Virtual Teams Series of 3 Online Workshops; Will Teach Virtual Teams how to Collaborate Remotely
No Comment Received
Leave A Reply